Flotek lifts 2026 outlook, sees revenue $360 million-$370 million and adjusted EBITDA $50 million-$54 million
FTK•International chemistry sales outlook
International chemistry revenue was $10.6 million in the second quarter.
Flotek expects second-half international chemistry sales to exceed $40 million.
2026 guidance raised again
Flotek lifted 2026 guidance again, projecting total revenue of $360 million-$370 million.
Adjusted EBITDA forecast was raised to $50 million-$54 million.
The prior 2026 outlook, set Aug. 4, called for revenue of $340 million-$350 million and adjusted EBITDA of $47 million-$51 million.
The midpoint of the new range implies 54% revenue growth and 58% adjusted EBITDA growth versus 2025 reported results.
